Paraphilia and other disturbed behavior associated with dopamimetic treatment for Parkinson's disease

Movement Disorders

Volumn 24, Issue 7, 2009, Pages 1091-1092

  Nielssen, Olav B ^a   Cook, Raymond J ^b   Joffe, Ron ^b   Meagher, Linton J ^b   Silberstein, Paul ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CYPROTERONE ACETATE; LEVODOPA; QUETIAPINE; TESTOSTERONE;

ADULT; ANAMNESIS; ASSAULT; BEHAVIOR DISORDER; BRAIN DEPTH STIMULATION; CASE REPORT; CLINICAL FEATURE; COMPULSIVE PERSONALITY DISORDER; DRUG DOSE INCREASE; DRUG SAFETY; DRUG TOLERANCE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; HUMAN; LETTER; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; SEXUAL DEVIATION; SUBTHALAMIC NUCLEUS; TESTOSTERONE BLOOD LEVEL; THEFT; TREATMENT RESPONSE;

ADULT; DOPAMINE AGENTS; HUMANS; MALE; MENTAL DISORDERS; PARAPHILIAS; PARKINSONIAN DISORDERS;

EID: 67651162177     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22388     Document Type: Letter

References (11)

1. Klos KJ, Bower JH, Josephs KA, et al. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 2005;11:381-386.
2. Cannas A, Solia P, Flores G, et al. Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: a rare case of iatrogenic paraphilia. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1539-1541.
3. Shapiro MA, Chang YL, Munson SK, et al. Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases. Parkinsonism Relat Disord 2006;12:392-395.
4. Courty E, Durif F, Zenut M, et al. Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease. Clin Neuropharmacol 1997;20:140-147.
5. Tellez C, Bustamente ML, Toro P, et al. Addiction to apomorphine: a clinical case-centred discussion. Addiction 2006;101: 1662-1665.
6. Quinn NP, Toone B, Lang AE, et al. Dopa dose-dependent sexual deviation. Br J Psychiatry 1983;142:296-298.
7. Gschwandtner U, Aston J, Renaud S, et al. Pathologic gambling in patients with Parkinson's disease. Clin Neuropharmacol 2001;24:170-172.
8. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007;64:1089-1096.
9. Riley DE. Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline. Clin Neuropharmacol 2002; 25:234-247.
10. Haussermann P, Goerker D, Beier K, et al. Low-dose cyproterone acetate treatment of sexual acting out in men with dementia. Int Psychogeriatr 2003;15:181-186.
11. Voon V, Kubu C, Krack P, et al. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006; 21(Supp):S305-S327.